Ocular Therapeutix has granted inducement equity awards to eleven newly hired non-executive employees. The awards, effective July 6, 2026, consist of stock options to purchase up to 34,700 shares and restricted stock units for 11,375 shares. The options have an exercise price of $9.66 per share, a ten-year term, and vest over four years. The restricted stock units vest over three years in equal annual installments. The grants were made under the company's 2019 Inducement Stock Incentive Plan as required by Nasdaq Listing Rule 5635(c)(4).
Ocular Therapeutix IncInducement equity grants to new employees, not a business development; neutral for stock.
Advanced Micro Devices Inc